Recombinant alpha-fetoprotein immunotherapy (Ural State Medical Academy)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant alpha-fetoprotein immunotherapy (Ural State Medical Academy)
Drug Alias NameProfetal
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2012/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUral State Medical Academy
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeJ05AP
Related LinksN/A